Intra-cellular Therapies, INC.

Biopharmaceutical company.

Based in NY

🤖

AI Overview

With $510K in lobbying spend across 15 quarterly filings, Intra-cellular Therapies, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.

$510K
Total Spend
4
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$40K
2023$130K
2024$180K
2025$160K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Intra-cellular Therapies, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.